Overview
Cancer is a group of diseases characterized by the uncontrolled proliferation of cells that acquire the ability to invade surrounding tissue and disseminate to distant organs. It originates from progressive genetic and epigenetic changes that activate oncogenes, inactivate tumor-suppressor genes, and dysregulate signaling pathways governing growth, survival, and genome stability. These molecular alterations define tumor behavior and increasingly form the basis for diagnosis, classification, and treatment selection through genetic and biomarker analysis. From a genetics and biomarker perspective, research focuses on identifying the mutations, expression signatures, and molecular features that drive initiation and progression and that can be measured to detect disease, stratify risk, and predict response. Representative work addresses the mutational landscape of TP53 in oral cancer, epigenetic biomarkers in head and neck cancer, and the molecular and cellular mechanisms underlying sporadic solid tumors and therapeutic resistance at relapse. Other lines of inquiry develop immunoassays and immunogenomic approaches for monitoring disease, model complex tumors for biomarker discovery, and examine compounds with anticancer activity. Studies of screening uptake, survival, and incidence trends connect these molecular insights to population outcomes. Collectively, the field links the biology of malignant transformation to actionable biomarkers, advancing earlier detection, precise classification, and individualized management across cancer types.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Targeting Mutational Landscape of TP53 in patients diagnosed with Oral Cancer living in Senegal
High-Throughput Complex Disease Modeling for Ethical Drug Discovery: Clinical Relevance of a NAM Platform for Cancer Biomarker Development
Epigenetic Biomarkers in Head and Neck Cancer
Correlating 13C Isotope in Oligomeric Proanthocyanidins with their Anticancer Properties
Molecular and Cell Biological Considerations in the Initiation and Development of Sporadic Non-Hereditary Solid Cancers
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
A Cancer Theory: The Central Nervous System’s Adaptive Changes Make Chronic Diseases Incurable
One Out of Five Women Practiced Cervical Cancer Screening in Felege Hiwot Referral Hospital, Amhara, North West Ethiopia
Survival among Breast Cancer Patients in a Tertiary Cancer Center in Brunei Darussalam
Secular Trend in the Incidence of Japanese Employees with Thyroid Cancer Undergoing Thyroidectomy from 2005 to 2014: a Retrospective Descriptive Study Using an Employment-Based Insurance Claims Database
Cellular Mechanics and Therapeutic Resistance of the Cancer Relapse
How this research is being cited
The 12 articles above have been cited 36 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Genes
-
2025 · Open Journal of Genetics
-
Maria Constantin et al. · 2024 · Frontiers in Oncology
-
2024 · Biomedical Research and Therapy
-
2023 · Cells
-
2023 · Cells
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
2023 · Medical Oncology
A sample of recent works citing this journal's research on Cancer, linking to each citing work.